Value of PCT When Diagnosing Candidemia
May 19, 2022 updated by: Johan Petersson, Karolinska University Hospital
This study is a retrospective analysis to identify and compare the shift in inflammatory biomarkers in ICU patients immediately before and after the first identification of candidemia.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
As above.
Study Type
Observational
Enrollment (Actual)
49
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Stockholm, Sweden, 17176
- Karolinska University Hospital Solna
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Intensive care patients
Description
Inclusion Criteria (all has to be fullfilled):
- ICU patients with blood cultures showing growth of Candida species
- clinical records including daily data on WBC, CRP, Procalcitonin and body temperature
Exclusion Criteria:
- Age lower than 18 years
- blood cultures with growth of Candida species before ICU admission
- incomplete records of daily WBC, CRP, Procalcitonin or body temperature
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Absolute procalcitonin concentration
Time Frame: 9 days
|
9 days
|
|
Shift (trend) procalcitonin concentration
Time Frame: 9 days
|
9 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
April 1, 2010
Primary Completion (ACTUAL)
December 31, 2015
Study Completion (ACTUAL)
December 12, 2021
Study Registration Dates
First Submitted
December 12, 2021
First Submitted That Met QC Criteria
May 19, 2022
First Posted (ACTUAL)
May 23, 2022
Study Record Updates
Last Update Posted (ACTUAL)
May 23, 2022
Last Update Submitted That Met QC Criteria
May 19, 2022
Last Verified
May 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EPN 2017/806-31 (Candida-PCT)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
No plan
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.